Pasar al contenido principal

PAPEL DEL METABOLISMO MITOCONDRIAL SOBRE LA FISIOPATOLOGIA DEL MUSCULO ESQUELETICO: ROL DE LAS DESHIDROGENASAS FAD-DEPENDIENTES ASOCIADAS A LA FOSFORILACION OXIDATIVA.

PID2019-104241RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis

  • Herrero Martín, Juan Cruz
  • Salegi, Beñat
  • Álvarez-Rivera, Gerardo
  • Domínguez-Zorita, Sonia
  • Rodríguez-Pombo, Pilar
  • Pérez, Belén
  • Calvo, Enrique
  • Paradela, Alberto
  • Miguez, David G.
  • Cifuentes, Alejandro
  • Cuezva, José M.
  • Formentini, Laura
Extended data is available for this paper at https://doi.org/10.1038/s42255-023-00956-y. The online version contains supplementary material available at https://doi.org/10.1038/s42255-023-00956-y., Coenzyme Q (Q) is a key lipid electron transporter, but several aspects of its biosynthesis and redox homeostasis remain undefined. Various flavoproteins reduce ubiquinone (oxidized form of Q) to ubiquinol (QH2); however, in eukaryotes, only oxidative phosphorylation (OXPHOS) complex III (CIII) oxidizes QH2 to Q. The mechanism of action of CIII is still debated. Herein, we show that the Q reductase electron-transfer flavoprotein dehydrogenase (ETFDH) is essential for CIII activity in skeletal muscle. We identify a complex (comprising ETFDH, CIII and the Q-biosynthesis regulator COQ2) that directs electrons from lipid substrates to the respiratory chain, thereby reducing electron leaks and reactive oxygen species production. This metabolon maintains total Q levels, minimizes QH2-reductive stress and improves OXPHOS efficiency. Muscle-specific Etfdh-/- mice develop myopathy due to CIII dysfunction, indicating that ETFDH is a required OXPHOS component and a potential therapeutic target for mitochondrial redox medicine., This work was supported by grants from the Ministerio de Ciencia e Innovación, Spain (PID2019-104241RB-I00 and PID2022-136738OB-I00, MCIN/AEI/10.13039/501100011033) and the Fundación Ramón Areces, Spain. Principal investigator: L.F. B.S.A. is supported by a FPU predoctoral grant (FPU2022/00218) and G.Á.-R. is supported by a Juan de la Cierva-Incorporación postdoctoral grant (IJC2019-041482-I), awarded by the Ministerio de Universidades (MU) and the Ministerio de Ciencia e Innovación (MC), respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chronic inhibition of the mitochondrial ATP synthase in skeletal muscle triggers sarcoplasmic reticulum distress and tubular aggregates

  • Sánchez-González, Cristina
  • Herrero Martín, Juan Cruz
  • Salegi Ansa, Beñat
  • Núñez de Arenas, Cristina
  • Stančič, Brina
  • Pereira, Marta P.
  • Contreras, Laura
  • Cuezva, José M.
  • Formentini, Laura
Tubular aggregates (TA) are honeycomb-like arrays of sarcoplasmic-reticulum (SR) tubules affecting aged glycolytic fibers of male individuals and inducing severe sarcomere disorganization and muscular pain. TA develop in skeletal muscle from Tubular Aggregate Myopathy (TAM) patients as well as in other disorders including endocrine syndromes, diabetes, and ageing, being their primary cause unknown. Nowadays, there is no cure for TA. Intriguingly, both hypoxia and calcium dyshomeostasis prompt TA formation, pointing to a possible role for mitochondria in their setting. However, a functional link between mitochondrial dysfunctions and TA remains unknown. Herein, we investigate the alteration in muscle-proteome of TAM patients, the molecular mechanism of TA onset and a potential therapy in a preclinical mouse model of the disease. We show that in vivo chronic inhibition of the mitochondrial ATP synthase in muscle causes TA. Upon long-term restrained oxidative phosphorylation (OXPHOS), oxidative soleus experiments a metabolic and structural switch towards glycolytic fibers, increases mitochondrial fission, and activates mitophagy to recycle damaged mitochondria. TA result from the overresponse of the fission controller DRP1, that upregulates the Store-Operate-Calcium-Entry and increases the mitochondria-SR interaction in a futile attempt to buffer calcium overloads upon prolonged OXPHOS inhibition. Accordingly, hypoxic muscles cultured ex vivo show an increase in mitochondria/SR contact sites and autophagic/mitophagic zones, where TA clusters grow around defective mitochondria. Moreover, hypoxia triggered a stronger TA formation upon ATP synthase inhibition, and this effect was reduced by the DRP1 inhibitor mDIVI. Remarkably, the muscle proteome of TAM patients displays similar alterations in mitochondrial dynamics and in ATP synthase contents. In vivo edaravone treatment in mice with restrained OXPHOS restored a healthy phenotype by prompting mitogenesis and mitochondrial fusion. Altogether, our data provide a functional link between the ATP synthase/DRP1 axis and the setting of TA, and repurpose edaravone as a possible treatment for TA-associated disorders., This work was supported by a grant from Ministerio de Ciencia e Innovación, Spain (PID2019-104241RB-I00). CSG was supported by BES-2017-079909 MINECO fellowship. The “Biobank of Cells, tissues and DNA from patients with neuromuscular diseases”, and the “Biobank of skeletal muscle, peripheral nerve, DNA and cell lines”, members of the Telethon Network of Genetic Biobanks (project no. GTB12001), funded by Telethon Italy, and of the EuroBioBank network, provided us with specimens.